Issues related to Medicare coverage of home infusion; issues related to the implementation of the Inflation Reduction Act.
2025 · 1st Quarter (Jan 1 - Mar 31)
ALNYLAM PHARMACEUTICALS, INC.
Filed by ALNYLAM PHARMACEUTICALS, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- Not reported
- Expenses
- $440,000.00
- Registrant
- ALNYLAM PHARMACEUTICALS, INC.
- Filing UUID
- 7e2793ed-5f06-480a-9d46-fdd01afc5454
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to veterans healthcare.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.